Spironolactone Tablet, Film Coated
Product Images NDC 48433-087

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 48433-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Safecor Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spironolactone Structural Formula (Image 01)

Chemical structure diagram of spironolactone showing its molecular framework with labeled carbon, hydrogen, and functional groups consistent with the steroidal structure typical of this active ingredient.*

FDA Label Image

Figure 1. Survival By Treatment Group In The Randomized Spironolactone Evaluation Study (Image 02)

A Kaplan-Meier survival curve chart comparing the probability of an outcome over 48 months in two groups: one receiving Spironolactone (n=822) and the other a placebo (n=841). The x-axis represents time in months, and the y-axis represents probability. The Spironolactone group shows higher probability over time compared to placebo, with a log-rank p-value less than 0.001.*

FDA Label Image

Figure 2. Hazard Ratios Of All-cause Mortality By Subgroup In The Randomized Spironolactone Evaluation Study (Image 03)

A forest plot displaying hazard ratios (HR) with 95% confidence intervals for multiple subgroups related to a clinical comparison between spironolactone and placebo. Subgroups include age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium level, digoxin, ACEI, and beta blocker use. The horizontal axis ranges from 0.2 to 1.4, with labels indicating 'Spironolactone better' on the left and 'Placebo better' on the right.*

FDA Label Image

Spironolactone 50 mg Tablets, Usp Unit Carton Label (Image 04)

Spironolactone 50 mg film-coated tablets, oral use, in a blister pack containing 100 tablets (10 x 10). The label shows drug name, strength, quantity, and manufacturer details: Mylan Pharmaceuticals Inc., Morgantown, WV, USA, made in Australia. Storage instructions indicate keeping at 20° to 25°C and protecting from light. Rx only.*

FDA Label Image

Unit Carton (Image 05)

Packaging label for Spironolactone tablets by Safecor Health LLC, featuring UDL branding. The label includes usage warnings, storage instructions, and distributor contact information. It notes the package is not child resistant and is for institutional use only, with a window for lot number and expiration date.*

FDA Label Image

Spironolactone 100 mg Tablets, Usp Unit Carton Label (Image 06)

Spironolactone 100 mg film-coated tablets packaging label shows 80 tablets (10 x 8) manufactured for Mylan Pharmaceuticals Inc. The label includes product name, strength, NDC 48433-089-08, a round tablet imprint marked 'M 437,' storage instructions, Rx only designation, and origin indicated as made in Australia.*

FDA Label Image

Spironolactone 25 mg Tablets, Usp Unit Carton Label (Image 07)

Spironolactone 25 mg film-coated tablets label by Safecor Health LLC. The label specifies oral tablet form, 25 mg strength, 100 tablets per package (10 x 10). It includes storage instructions (20°C to 25°C), a barcode, and manufacture details indicating Mylan Pharmaceuticals Inc. as manufacturer. The label is marked Rx only.*

FDA Label Image

Unit Carton (Image 08)

Packaging label for Spironolactone tablets from Safecor Health LLC, featuring the UDL logo and company name on a blue background. The label includes usage warnings such as the package not being child resistant, for institutional use only, and instructions to keep out of reach of children. It also notes the container’s light resistance and a window for lot number and expiration date. Manufacturer contact information is provided.*

FDA Label Image

Unit Carton (Image 09)

Packaging label for Spironolactone tablets by Safecor Health LLC, featuring the UDL logo. The label includes cautions regarding child safety, institutional use, drug storage, and light-resistance of the container. Contact information for Safecor Health is provided, including a phone number and website.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.